1124 related articles for article (PubMed ID: 25449238)
21. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
Cohen Stuart JW; Velema M; Schuurman R; Boucher CA; Hoepelman AI
J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397
[TBL] [Abstract][Full Text] [Related]
22. Characterization of occult hepatitis B virus infection among HIV positive patients in Cameroon.
Gachara G; Magoro T; Mavhandu L; Lum E; Kimbi HK; Ndip RN; Bessong PO
AIDS Res Ther; 2017 Mar; 14(1):11. PubMed ID: 28270215
[TBL] [Abstract][Full Text] [Related]
23. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
Rodríguez-Torres M; Gonzalez-Garcia J; Bräu N; Solá R; Moreno S; Rockstroh J; Smaill F; Mendes-Correa MC; DePamphilis J; Torriani FJ;
J Med Virol; 2007 Jun; 79(6):694-700. PubMed ID: 17457912
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B virus DNA in sera of blood donors and of patients infected with hepatitis C virus and human immunodeficiency virus.
Gonçales FL; Pereira JS; Da Silva C; Thomaz GR; Pavan MH; Fais VC; Magna LA; Gonçales NS
Clin Diagn Lab Immunol; 2003 Jul; 10(4):718-20. PubMed ID: 12853411
[TBL] [Abstract][Full Text] [Related]
25. High seroprevalence of HBV and HCV infection in HIV-infected adults in Kigali, Rwanda.
Rusine J; Ondoa P; Asiimwe-Kateera B; Boer KR; Uwimana JM; Mukabayire O; Zaaijer H; Mugabekazi J; Reiss P; van de Wijgert JH
PLoS One; 2013; 8(5):e63303. PubMed ID: 23717409
[TBL] [Abstract][Full Text] [Related]
26. Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients.
Lo Re V; Frank I; Gross R; Dockter J; Linnen JM; Giachetti C; Tebas P; Stern J; Synnestvedt M; Localio AR; Kostman JR; Strom BL
J Acquir Immune Defic Syndr; 2007 Mar; 44(3):315-20. PubMed ID: 17159655
[TBL] [Abstract][Full Text] [Related]
27. Presence of anti-HBc is associated to high rates of HBV resolved infection and low threshold for Occult HBV Infection in HIV patients with negative HBsAg in Chile.
Vargas JI; Jensen D; Sarmiento V; Peirano F; Acuña P; Fuster F; Soto S; Ahumada R; Huilcaman M; Bruna M; Jensen W; Fuster F
J Med Virol; 2016 Apr; 88(4):639-46. PubMed ID: 26381185
[TBL] [Abstract][Full Text] [Related]
28. Occult hepatitis B virus infection in a Kenyan cohort of HIV infected anti-retroviral therapy naïve adults.
Salyani A; Shah J; Adam R; Otieno G; Mbugua E; Shah R
PLoS One; 2021; 16(1):e0244947. PubMed ID: 33406137
[TBL] [Abstract][Full Text] [Related]
29. PREVALENCE OF OCCULT HEPATITIS B INFECTION IN IRANIAN CANCER PATIENTS BEFORE CHEMOTHERAPY TREATMENT.
Baghbanian M; Halvani M; Roghani HS; Lotfi MH; Yazdi MF; Vahedian-Ardakani HA
Arq Gastroenterol; 2016; 53(3):175-9. PubMed ID: 27438423
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and characteristics of hepatitis B and C virus infections in treatment-naïve HIV-infected patients.
Reuter S; Oette M; Wilhelm FC; Beggel B; Kaiser R; Balduin M; Schweitzer F; Verheyen J; Adams O; Lengauer T; Fätkenheuer G; Pfister H; Häussinger D
Med Microbiol Immunol; 2011 Feb; 200(1):39-49. PubMed ID: 20853118
[TBL] [Abstract][Full Text] [Related]
31. Occult hepatitis B virus infection among chronic hemodialysis patients in Alexandria, Egypt.
Helaly GF; El Ghazzawi EF; Shawky SM; Farag FM
J Infect Public Health; 2015; 8(6):562-9. PubMed ID: 26026236
[TBL] [Abstract][Full Text] [Related]
32. Seroprevalence of hepatitis B and C viruses and risk factors in HIV infected children at the Felgehiwot referral hospital, Ethiopia.
Abera B; Zenebe Y; Mulu W; Kibret M; Kahsu G
BMC Res Notes; 2014 Nov; 7():838. PubMed ID: 25421947
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B and/or C co-infection in HIV infected patients: a study in a tertiary care centre from South India.
Chandra N; Joshi N; Raju YS; Kumar A; Teja VD
Indian J Med Res; 2013 Dec; 138(6):950-4. PubMed ID: 24521641
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of hepatitis B virus (HBV) co-infection in HBV serologically-negative South African HIV patients and retrospective evaluation of the clinical course of mono- and co-infection.
Firnhaber C; Chen CY; Evans D; Maskew M; Schulz D; Reyneke A; Kramvis A
Int J Infect Dis; 2012 Apr; 16(4):e268-72. PubMed ID: 22305987
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and impact of hepatitis B and C virus co-infections in antiretroviral treatment naïve patients with HIV infection at a major treatment center in Ghana.
Sagoe KW; Agyei AA; Ziga F; Lartey M; Adiku TK; Seshi M; Arens MQ; Mingle JA
J Med Virol; 2012 Jan; 84(1):6-10. PubMed ID: 22095533
[TBL] [Abstract][Full Text] [Related]
36. Occult hepatitis B virus infection in HIV-infected Lebanese patients with isolated antibodies to hepatitis B core antigen.
Ramia S; Mokhbat J; Ramlawi F; El-Zaatari M
Int J STD AIDS; 2008 Mar; 19(3):197-9. PubMed ID: 18397562
[TBL] [Abstract][Full Text] [Related]
37. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
[TBL] [Abstract][Full Text] [Related]
38. Prevalence, risk factors and genotypes of hepatitis B infection among HIV-infected patients in the State of MS, Central Brazil.
Freitas SZ; Soares CC; Tanaka TS; Lindenberg AS; Teles SA; Torres MS; Mello FC; Mendes-Corrêa MC; Savassi-Ribas F; Motta-Castro AR
Braz J Infect Dis; 2014; 18(5):473-80. PubMed ID: 24662138
[TBL] [Abstract][Full Text] [Related]
39. Integrated HIV surveillance finds recent adult hepatitis B virus (HBV) transmission and intermediate HBV prevalence among military in uncharacterized Caribbean country.
O'Connor SM; Mixson-Hayden T; Ganova-Raeva L; Djibo DA; Brown M; Xia GL; Kamili S; Jacobs M; Dong M; Thomas AG; Bulterys M; Hale B
PLoS One; 2019; 14(10):e0222835. PubMed ID: 31574098
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of hepatitis B and C and relationship to liver damage in HIV infected patients attending Joint Clinical Research Centre Clinic (JCRC), Kampala, Uganda.
Baseke J; Musenero M; Mayanja-Kizza H
Afr Health Sci; 2015 Jun; 15(2):322-7. PubMed ID: 26124775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
